United States: Consumer Protection

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

States are playing a critical role in the development of AI policy in the United States, as serious legislative efforts at the federal level remain stalled...

Our notable ruling roundup aims to keep our readers up to date on recent rulings in the food & consumer packaged goods space.

Sectoral tariffs are emerging as a preferred tool for the White House that leaves targeted industries, and those reliant on their import supply, subject to appreciably higher customs duties on imported goods.

In a recent webinar hosted by Kelley Drye, Nevada Attorney General Aaron D. Ford and Chief Deputy of Consumer Protection Mark Krueger shared valuable insights...

In August 2022, certain aggrieved employees of the insured employer sued the employer and two other employees for harassment and retaliation after the employees reported patient abuse and neglect at the employer's medical facility.

POM Wonderful v FTC - Both Sides Claim Victory even though the Court says: "neither side’s position as to the claims made or adequacy of substantiation has been totally vindicated."

On May 30, 2012, the public comment period began for proposed regulations issued by thirteen New York State agencies (including the Department of Health, the Office of Mental Health, and the Office of Children and Family Services) seeking to limit the executive compensation paid by, and administrative costs of, service providers that receive State funding.

On May 21, 2012, the Ninth Circuit Court of Appeals held that because the use of medical marijuana remains illegal under federal law, the Americans with Disabilities Act (ADA) does not protect against discrimination on the basis of medical marijuana use, even if that use is in accordance with state law explicitly authorizing such use.

States are playing a critical role in the development of AI policy in the United States, as serious legislative efforts at the federal level remain stalled...

On March 31, 2025, Congress saw the reintroduction of H.R. 2511, the Sarah Katz Caffeine Safety Act.

Per- and polyfluoroalkyl substances (PFAS), often dubbed "forever chemicals," continue to be a major focus of environmental regulation across the United States.